OncoZenge AB
ONCOZ | FN
Overview
Corporate Details
- ISIN(s):
- SE0015504097
- LEI:
- 2549003980RBCR6NIF38
- Country:
- Sweden
- Address:
- Gustavslundsvagen 34, 5 tr, 167 51 Bromma
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
OncoZenge AB focuses on developing treatments for oral pain caused by cancer therapies. Their solutions aim to improve patient quality of life.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-07 | Stian Kildal | Other | Buy | 20,439 | 85,026.24 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Valneva SE | France | VLA | |
|
VENTURE LIFE GROUP PLC | United Kingdom | VLG | |
|
Vetoquinol SA | France | VETO | |
|
Vicore Pharma Holding | Sweden | VICO | |
|
Vifor Pharma AG | Switzerland | VIFN | |
|
Vimian Group AB | Sweden | VIMIAN | |
|
Virbac | France | FR000 | |
|
Vistin Pharma | Norway | VISTN | |
|
Vivesto | Sweden | VIVE | |
|
Xlife Sciences AG | Switzerland | XLS |